Further Trichostatin A manufacturer functionalization of GNPs with receptor molecules, enabling specific antibody-antigen or ligand-receptor interactions, may allow targeting to specific tissues or cells [114]. Such targeted controlled release of NO could be an effective therapy for hypoxic respiratory failure associated with pulmonary hypertension. Polizzi et al. demonstrated that NO can be efficiently

Inhibitors,research,lifescience,medical stored by covalent linking to polyamine-stabilized GNPs via formation of acid labile N-diazeniumdiolate [115]. Additionally, they showed effective NO release from the water-soluble nanocontainers under acidic conditions (pH 3). pH-responsive materials have applications in drug delivery due to the mild acidic environment of inflamed tissues and tumors (pH ~6.8) and in such cellular vesicles as endosomes (pH Inhibitors,research,lifescience,medical ~5.5–6.0) and lysosomes (pH ~4.5–5.0) (Figure 5) [116]. Figure 5 Nanocontainers for NO storage. Reprinted

from Ghosh et al. [116], with the permission of Elsevier. GNPs have been Inhibitors,research,lifescience,medical shown to catalyze NO generation whenever they come into contact with fresh blood serum. Meanwhile, NO has a relatively short lifetime in the blood due to its reactivity with various blood components, including hemoglobin. More abundant and stable forms of NO in the blood are S-nitroso adducts with thiol groups (RSNOs), such as S-nitrosoalbumin (AlbSNO), S-nitrosocysteine (CysNO), and S-nitrosoglutathione (GSNO) [117]. These compounds may function as NO-carrying systems, prolonging the half-life and spatial impact of NO. NO plays an important role Inhibitors,research,lifescience,medical in the control of vascular tone. It activates the soluble guanylyl-cyclase (sGC) and G-kinase protein, which decreases the cytosolic calcium concentration ([Ca2+]c) in the vascular smooth muscle cells (VSMCs) [118, 119]. GNPs have been synthesized and functionalized with nitrosyl ruthenium complex to investigate if this system potentiates the NO release Inhibitors,research,lifescience,medical and the vascular relaxation induced by the nitrosyl ruthenium complex. This NO-release

GNP system induced a dose-dependent relaxation in endothelium denuded aortic rings better than the complex only [120]. 4.2. Silica Nanoparticles The physiochemical properties, Tryptophan synthase stability and ability to form tunable porous structures with tailored surface functionalities has led to the possibility of using of silica nanoparticles (SiNPs) in the controlled delivery of drugs, biocides, genes, and proteins. Other advantages to SiNPs is that they are nontoxic and that their synthesis and isolation are straightforward [121]. SiNP nanoconjugation with NO donors is also advantageous [122], such as inorganic-organic hybrid SiNPs, functionalized ceramic materials prepared from silicon dioxide.